INTRODUCTION
Prion diseases or TSEs (transmissible spongiform encephalopathies) are a rare group of invariably fatal neurodegenerative illnesses affecting humans and animals. They are classified as sporadic, genetic or infectious forms. In humans, sCJD [sporadic CJD (Creutzfeldt-Jakob disease)] is the most common prion disease. In general, CJD pathologically manifests as spongiosis, neuronal loss, astrogliosis and a clinical syndrome characterized by dementia, ataxia and myoclonus. Amyloid deposits, composed mainly of pathogenic agents called prions, may parallel the pathology of the disease. Prions are the abnormal misfolded forms resulting from the post-translational conversion of PrP C [cellular host-encoded PrP (prion protein)] [1] . Genetic prion diseases are caused by mutations in the HuPrP (human PrP) gene (PRNP) and include GSS (Gerstmann-Sträussler-Scheinker) syndrome, FFI (fatal familial insomnia) and fCJD (familial CJD). The acquired forms are transmitted among humans (iatrogenic CJD and Kuru) or from animals to humans (variant CJD).
Prions or PrP Sc (scrapie isoform of PrP) are the sole causative agents of TSEs [1] , and PrP Sc is believed to self-propagate by a mechanism involving its binding to PrP C , followed by the conversion of PrP C into PrP Sc [2] . The structure of PrP Sc has not yet been resolved, although several models have been proposed [3] . PrP Sc differs from PrP C in several properties such as the higher content of β-sheet structure, partial protease resistance and amyloidogenicity [1] . PrP C is a cell-surface GPI (glycosylphosphatidylinositol)-anchored glycoprotein mostly expressed in the central and peripheral nervous system by different cell types in mammals [4] . Although PrP C influences several processes in the nervous system, its physiological function has not been established with certainty. A wealth of information exists on the various structural studies carried out on WT (wild-type) and mutant recombinant PrP molecules. As revealed by its atomic structure, the mature PrP expressed by different mammals is very similar [3] . Local sequence and structure variations are most prominently localized in the β 2 -α 2 loop and in the C-terminal part of the α 3 helix. The globular structured domain (residues 125-231) of recombinant WT HuPrP consists of three α-helices (α 1 , α 2 and α 3 ) and two antiparallel β-strands (β 1 and β 2 ) [5] . Helices α 2 and α 3 are linked by a Cys 179 -Cys 214 disulfide bridge. In contrast, the N-terminal segment of the molecule (residues 23-124) is highly flexible and largely disordered [6] .
Key evidence exists supporting the link between mutations in PRNP and genetic prion diseases. Several mutations linked to fCJD, GSS and FFI have been identified (Figure 1) . In vivo experiments demonstrate that changing the PrP amino acid sequence is sufficient to generate de novo prions. KI (knockin) mice expressing the FFI-causing D178N/Met 129 Abbreviations used: CJD, Creutzfeldt-Jakob disease; 3D, three-dimensional; fCJD, familial CJD; FFI, fatal familial insomnia; GPI, glycosylphosphatidylinositol; GSS, Gerstmann-Sträussler-Scheinker; HSQC, heteronuclear single-quantum coherence; KI, knockin; NOE, nuclear Overhauser effect; PrP, prion protein; PrP C , cellular host-encoded PrP; PrP Sc , scrapie isoform of PrP; HuPrP, human PrP; MoPrP, mouse PrP; RMSD, root mean square deviation; sCJD, sporadic CJD; Tg, transgenic; TSE, transmissible spongiform encephalopathy; WT, wild-type. 1 These authors contributed equally to this work. 2 Present address: Department of Chemistry, University of Zagreb, Horvatovac 102A, HR-10000 Zagreb, Croatia. 3 Present address: Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Pawinskiego 5a, 02-106 Warsaw, Poland. 4 Correspondence may be addressed to either of these authors (email janez.plavec@ki.si or giuseppe.legname@sissa.it). Chemical shift data have been deposited in the Biological Magnetic Resonance Data Bank (http://www.bmrb.wisc.edu) under accession numbers 17780 for HuPrP(E219K) and 18426 for WT HuPrP. The structural co-ordinates reported will appear in the PDB under accession codes 2LFT for HuPrP(E219K) and 2LSB for WT HuPrP. Upper panel: the human PRNP gene with all currently identified mutations and two disease-influential polymorphisms [40] . The pre-pro PrP consists of residues 23-231, an N-terminal translocation signal peptide and a C-terminal GPI-anchor signal peptide. Lower panel: cartoon representation for the superimposition of 20 energy-minimized conformers of the HuPrP(E219K) folded domain. Mutated Lys 219 is depicted in pink.
mutation developed a spontaneous transmissible disease with neuropathological traits similar to FFI [7] . Recently, Tg (transgenic) mice have been reported to express chimaeric PrP constructs inducing the rigidity of the β 2 -α 2 loop and exhibiting transmission barriers against certain prion strains [8] . These findings underline the role of the β 2 -α 2 loop conformation in modulating prion susceptibility and infectivity. Although point mutations are responsible for genetic prion diseases, polymorphisms in PRNP influence their aetiology and neuropathology. The polymorphic residue at codon 129 (M129V) has been studied extensively. Methionine homozygosis at codon 129 is considered a risk factor for sporadic and acquired CJD [9] . Another naturally occurring HuPrP polymorphism, E219K, was found to protect against sCJD. Heterozygosis at codon 219 was initially reported in the Japanese population [10] and later also in other Asiatic populations [11] . The absence of confirmed cases of sCJD patients carrying the E219K polymorphism argues that E219K heterozygosis acts as a protective factor against sCJD. In addition, the protective effect of E219K substitution, also denoted as the 'dominantnegative effect', has been reported in several experimental studies both in vivo and in vitro. Tg mouse studies have supported this notion. In fact, MoPrP (mouse PrP)(Q218K)Prnp + / + mice overexpressing the Q218K variant (homologous with human Lys 219 ) exhibited a prolonged incubation time when infected with the RML (Rocky Mountain Laboratory) prion strain [12] . KI mice expressing HuPrP heterozygous for lysine at codon 219 showed resistance to prion diseases when infected with brain homogenates from sCJD patients. Notably, KI mice homozygous for glutamate or lysine at codon 219 are susceptible to prion infection, suggesting that only E219K heterozygosis represents a protective factor against prion diseases [13] . Dominant-negative inhibition of prion replication was also reported in vitro using scrapie-infected neuroblastoma cells expressing MoPrP(Q218K) [14, 15] , in fibrillization experiments starting from recombinant MoPrP(Q218K) [16] and in PMCA (protein misfolding cyclic amplification) reactions [17] . In order to understand a possible correlation between structural effects imposed by E219K polymorphism and their influence on susceptibility to prion diseases, we determined a high-resolution 3D (three-dimensional) NMR structure of the recombinant HuPrP (residues 90-231) carrying an E219K substitution. Since the conversion of PrP C into PrP Sc seems to occur in the acidic endosomal compartments [18] , we performed our measurements at pH 5.5. To allow for direct comparison between HuPrP(E219K) and WT protein, we examined the structure of WT HuPrP (residues 90-231) under the same experimental conditions. Additionally, the structure of HuPrP(E219K) was compared with the previously resolved NMR structures of the proteins carrying Q212P [19] and V210I [20] mutations causing GSS and fCJD respectively. Our structural data revealed that the E219K polymorphism introduces novel structural and dynamic features with respect to the WT protein and pathological analogues. The structural findings of the present study enabled us to propose possible critical epitopes on the HuPrP structure that could be involved in the conversion of PrP C into PrP Sc and may account for the protective effect of E219K polymorphism in inhibiting prion replication.
EXPERIMENTAL

Plasmid construction and protein expression and purification
WT HuPrP(90-231, Met 129 ) was amplified from genomic human DNA by PCR using Vent polymerase (New England Biolabs) and primers 5 -GGAATTCCATATGAAGAAGCG-CCCGAAGCCTGGA-3 and 5 -CGGGATCCCTAATGGTGAT-GGTGATGGTGGCTCGATCCTCTCTGGTAATAGGCCTGA-3 . The reverse primer encodes an uncleavable His 6 tag at the C-terminus. After digestion with the enzymes NdeI and BamHI (New England Biolabs), the restricted fragment was ligated into the pET-11a vector (Novagen). The E219K polymorphism was constructed using the QuikChange ® kit (Stratagene), primers 5 -GTATCACCCAGTACAAGAGGGAATCTCAG-3 and 5 -CTGAGATTCCCTCTTGTATGGGTGATAC-3 , and HuPrP(90-231, Met 129 ) as template. The cloned DNA sequences were verified by sequencing. Proteins were expressed, purified and refolded according to our previous protocol [19] .
NMR spectroscopy
All NMR experiments were performed on ( 13 15 N heteronuclear NOEs (nuclear Overhauser effects) were performed at two different magnetic fields (14.1 T and 18.8 T) and at 298 K. Standard triple-resonance NMR experiments were used for assignments and to obtain distance restraints. Chemical shifts were referenced considering external DSS (sodium 2,2-dimethyl-2-silapentane-5-sulfonate). All recorded spectra were processed by NMRPipe software [21] and analysed with Sparky (Goddard, T.D. and Kneller, D.G., SPARKY 3, University of California, San Francisco) and CARA software [23] .
Structure calculations
The initial structure calculations were performed using CYANA 3.0 [24] . CYANA was also used to convert NOE intensities into upper distance restraints according to an inverse sixth power peak volume-to-distance relationship as well as to remove meaningless restraints. The automatic NOE assignment procedure [25] yielded 2252 and 2531 distance restraints for HuPrP(E219K) and WT HuPrP respectively ( Table 1 ). The 20 conformers of each protein with the lowest residual target function values were energy-minimized in a water shell with the YASARA program suite (http://www.yasara.org) [26] . The final ensemble of the 20 lowest-energy structures of HuPrP(E219K) and WT HuPrP exhibited good convergence and very high definition. A [27] . ‡Ensemble of structures was validated and analysed using the WHAT IF program [28] .
validation procedure using PROCHECK-NMR [27] and WhatIF [28] demonstrated that the final family of 3D structures of both HuPrP(E219K) and WT HuPrP agree with the distance restraints and offer good geometry and side chain packing. 13 C resonances in aliphatic and aromatic side chains were nearly as complete as those of side chain amide groups of asparagine and glutamine residues. Overall, the completeness of resonance assignments was 97 %.
High-resolution 3D structures of HuPrP(E219K) and WT protein
Structure calculation for HuPrP(E219K) was based on nearly complete resonance assignments and a total of 2252 NOE distance restraints derived from 15 N-and 13 C-edited NOESY-HSQC 3D experiments. A total of 545 medium-and 509 long-range distance restraints led to the average backbone RMSDs (root mean square deviations) for the polypeptide segment 125-228 of 0.66 + − 0.12 Å (1 Å = 0.1 nm) for backbone and 1.06 + − 0.14 Å for heavy atoms. The complete structural statistic is summarized in Table 1 .
The NMR structure of the HuPrP(E219K) protein comprises an N-terminal flexible polypeptide segment (residues 90-124) and a well-structured C-terminal segment (residues 125-231) for which a detailed structure was obtained. The flexibility of the N-terminal segment is characterized by reduced 15 N R 2 relaxation rates, negative { 1 H}-15 N heteronuclear NOEs 15 N R 2 rates of these three residues are distinctly higher (see below). Therefore the inability to observe some of the backbone amide resonances from the β 2 -α 2 loop region in the ( 1 H, 15 N)-HSQC spectrum could be attributed to the line broadening caused by conformational exchange processes at micro-to milli-second timescales.
As suggested by reduced { 1 H}-15 N heteronuclear NOEs, increased 15 N R 1 and reduced 15 N R 2 relaxation rates ( Figure 3 ) in combination with the absence of long-range NOE contacts (Supplementary Figure S1) , some structural disorder within the folded part of HuPrP(E219K) can be observed for the last four residues at the C-terminal end of the protein. 
T (purple for WT and brown for E219K) and 18.8 T (blue for WT and green for E219K).
A high-resolution NMR structure of WT HuPrP at pH 5.5 was determined based on a total of 2531 NOE distance restraints comprising 1241 intra-residue and sequential, 572 medium-range and 718 long-range distance restraints. The average RMSD values relative to the mean co-ordinates are 0.36 + − 0.09 Å for the backbone, and 0.75 + − 0.14 Å for the heavy atoms (residues 125-228). The summary of the structural statistic is provided in Table 1 .
The 3D structure of WT HuPrP at pH 5.5 is highly similar to the previously reported structure of the WT protein resolved at pH 4.5 [5] . The two structures are superimposable on the backbone atoms with an RMSD value of 1.1 Å. The most apparent differences occur in the α 1 helix and within the β 2 -α 2 loop region. In the structure of the WT protein at pH 4.5, the α 1 (blue, PDB code 2LEJ) using GETAREA [41] . Solvent accessibility is >50 % for highly exposed residues, 20-50 % for boundary residues and <20 % for buried residues. Full data are available in Supplementary Figure S2 
Tertiary contacts in the HuPrP(E219K) protein
Lys 219 is located close to the C-terminal end of the α 3 helix and is exposed to solvent, which is in agreement with a solvent accessibility calculation ( Figure 4A ). The α 2 -α 3 region in HuPrP is stabilized by several salt bridges and a large number of hydrophobic interactions. Detailed analysis of the high-resolution structure of the E219K polymorphism revealed that replacement of Glu 219 with a lysine residue does not interfere with stabilizing interactions nor does it induce significant structural changes in the proximity of the mutation site. We have identified 75 longrange NOE distance restraints between helices α 2 and α 3 . The large number of restraints supports the existence of close contacts between the two secondary structure elements that contribute to overall stability of the globular domain. Furthermore, they demonstrate pronounced tertiary interactions between the Nterminal segment of the α 2 helix and the C-terminal part of the α 3 helix. A total of 28 long-range NOE contacts support the hydrophobic nature of interactions between Phe 175 and Val 176 in the α 2 helix and Ile 215 and Tyr 218 in the α 3 helix. Furthermore, NOE data revealed very close packing between the side chains of several residues situated at the interface of the β 1 -α 1 loop, the α 1 helix, the α 1 -β 2 loop and the α 3 helix. Figure 6A ).
DISCUSSION
Several pathogenic mutations and relevant polymorphisms have been identified in PRNP. Influential polymorphisms can affect the susceptibility to, and phenotype of, prion diseases. CJD surveillance programmes established a high incidence of the E219K polymorphism in East Asian populations [10, 11] . The absence of confirmed cases of sCJD patients carrying this polymorphism argues that E219K heterozygosis acts as a protective factor against sCJD. Several experimental data support the dominant-negative effect of E219K polymorphism, confirming that this substitution is able to halt prion replication in vivo. Current theories about the protective effect of the E219K variant propose two models. It has been suggested that Glu 168 and Glu 219 are located in a discontinuous epitope for a putative yet unidentified facilitator of prion conversion denoted as 'protein X'. The replacement of Gln 168 and Gln 218 (in MoPrP) with arginine and lysine residues respectively prevented the formation of PrP Sc both in Tg mice and in neuroblastoma cells overexpressing these variants [12, 15] . The authors of these previous studies speculated that the dominant-negative PrP C variants inhibit conversion into PrP Sc by binding to 'protein X' and sequestering it from the replication process. An alternative model excludes the involvement of 'protein X'. It suggests that individuals heterozygous for lysine at codon 219 are protected against sCJD because the PrPs derived from two allelic variants interfere with each other in the conversion process due to their incompatible structures. This model is based on the evidence that KI mice expressing HuPrP(E219K) are resistant to prion diseases only under heterozygosis [13] . The structural basis responsible for the protective effect of the E219K polymorphism has so far remained elusive. To gain insight into the structural determinants underlying the protective influence of this naturally occurring polymorphism, we have determined its high-resolution 3D structure based on NMR datasets and compared it with the 3D structures of the WT and HuPrP proteins with pathological Q212P and V210I mutations. Although the structures of HuPrP carrying Q212P and V210I mutations have been examined recently [19, 20] employing a protocol that is identical with that for HuPrP(E219K), a solutionstate NMR structure of WT HuPrP reported previously was resolved under slightly different conditions [5] . Therefore, to enable direct comparison, in the present study we redetermined the NMR structure of WT HuPrP under exactly the same experimental conditions as those used for HuPrP(E219K).
Comparison of the folded domains (residues 125-228) of HuPrP(E219K) and WT proteins revealed that they are very similar with a backbone RMSD of 1.22 Å ( Figure 7A ). There are no significant differences between the two structures in the vicinity of the substitution site. Although the E219K variant did not induce significant local structural changes, it affected Positive and negative charges are depicted in blue and red respectively. The residue at position 219 is circled. The potentials were calculated at experimental pH 5.5 using programs PDB2PQR [42] , APBS [43] and PROPKA [44] .
or positive charge in the HuPrP(E219K) protein. Distribution of surface electrostatic potential also differs at the N-terminus of the α 3 helix, which displays neutral charge in the WT and mostly positive charge in the HuPrP(E219K) protein.
Moreover, careful inspection of the 3D structure of HuPrP(E219K) pointed to rearrangements of some residues in the β 1 [32] . Recently, we determined NMR structures of the HuPrPs carrying Q212P [19] and V210I [20] mutations causing GSS and fCJD respectively. Unlike the HuPrP(E219K) and WT proteins, the structures of Q212P and V210I mutants point to (Figure 4 ). Similar findings have also been reported in the NMR structure of the E200K mutant [33] , X-ray structures of F198S and D178N mutants [34] and in independent MD (molecular dynamics) studies [35] [36] [37] . These findings indicate that the structural disorder of the β 2 -α 2 loop region together with the increased distance between the loop and the α 3 helix represent key pathological structural features.
Different experimental studies suggested that the conformation of the β 2 -α 2 loop plays a role in TSE transmission and susceptibility. It has been postulated that mammals carrying a flexible β 2 -α 2 loop could be easily infected by prions, whereas prions are poorly transmissible to animals carrying a rigid loop [8] . Notably, horses and rabbits display resistance to prion infections and do not develop spontaneous prion diseases. NMR studies showed that their PrP structures are characterized by a rigid β 2 -α 2 loop and by closer contacts between the loop and α 3 helix [38, 39] . Thus it seems that prion resistance is enciphered by the amino acid composition of the β 2 -α 2 loop and its long-range interactions with residues in the C-terminal portion of the α 3 helix. Interestingly, our NMR data imply that the β 2 -α 2 loop in HuPrP(E219K) displays a tendency toward 3 10 -helical conformation, thus being somewhat better defined with respect to the same region in the WT protein and other disease-prone PrPs. This local structural feature of E219K polymorphism may further account for its protective influence against sCJD.
In conclusion, the results of the present study suggest that the structural determinants of the dominant-negative effect of the E219K polymorphism are enciphered by the perturbation of the surface charge and by subtle structural rearrangements most prominently localized in the β 2 -α 2 loop region. Variations in the distribution of electrostatic potential on the surface of the HuPrP(E219K) protein with respect to the WT are remarkable considering that only individuals heterozygous at codon 219 seem to be resistant to sCJD. Our findings suggest that different distribution of charges in the WT and HuPrP(E219K) proteins may facilitate intermolecular interactions between the two allelic variants, thus sequestering them from the early stages of the fibrillization process or inhibiting interactions with an as yet unknown facilitator of prion conversion. These results are consistent with previous observations and provide a structural explanation for the protective effect of the dominant-negative E219K polymorphism.
AUTHOR CONTRIBUTION
Giuseppe Legname and Janez Plavec conceived and designed the experiments. Ivana Biljan, Gabriele Giachin and Gregor Ilc performed the experiments. Ivana Biljan, Gabriele Giachin, Gregor Ilc, Igor Zhukov, Janez Plavec and Giuseppe Legname analysed the data. Gabriele Giachin and Giuseppe Legname contributed reagents, materials and analysis tools. Ivana Biljan, Gabriele Giachin, Gregor Ilc, Igor Zhukov, Janez Plavec and Giuseppe Legname wrote the paper.
Figure S2 Average values of solvent accessibility (%) per residues
